Trials / Completed
CompletedNCT03347357
Pharmacokinetics of Tacrolimus in Children
Population Pharmacokinetics of Tacrolimus in Children With Nephrotic Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 1 Month – 18 Years
- Healthy volunteers
- Not accepted
Summary
the present study was conducted to assess the population pharmacokinetics of tacrolimus in children with nephrotic syndrome and to use these data to calculate an optimal dosing regimen of tacrolimus for use in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | Tacrolimus was administered orally at a dose of 0.05 mg/kg/dose twice daily (bid) for children with nephrotic syndrome. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
- First posted
- 2017-11-20
- Last updated
- 2017-11-20
Source: ClinicalTrials.gov record NCT03347357. Inclusion in this directory is not an endorsement.